Pricing Term Sheet

 

Term sheet

 

Registration Statement No. 333-158939

 

 

 

To prospectus dated May 1, 2009
preliminary prospectus supplement dated September 7, 2010

 

Filed Pursuant to Rule 433 of the Securities Act of 1933

 

Free Writing Prospectus Dated September 7, 2010

 

Hospira, Inc.

 

$500,000,000 5.600% Notes due 2040

 

Issuer:

 

Hospira, Inc.

 

 

 

Principal Amount:

 

$500,000,000

 

 

 

Maturity Date:

 

September 15, 2040

 

 

 

Trade Date:

 

September 7, 2010

 

 

 

Original Issue Date (Settlement):

 

September 10, 2010

 

 

 

Interest Accrual Date:

 

September 10, 2010

 

 

 

Issue Price (Price to Public):

 

99.481%

 

 

 

Coupon:

 

5.600%

 

 

 

Benchmark Treasury:

 

4.375% due 05/15/40

 

 

 

Benchmark Treasury Price and Yield:

 

112-12; 3.686%

 

 

 

Spread to Benchmark Treasury:

 

195 basis points

 

 

 

Yield:

 

5.636%

 

 

 

Interest Payment Period:

 

Semi-Annually

 

 

 

Interest Payment Dates:

 

March 15 and September 15, commencing March 15, 2011

 

 

 

Day Count Convention:

 

30/360

 

 

 

Optional Make-Whole Redemption:

 

As a whole or in part, at Hospira’s option, at any time or from time to time, on not less than 30 nor more than 60 days’ notice, if redeemed (i) before March 15, 2040 (six months prior to the maturity date of the notes), the notes will be redeemed at a price equal to the greater of (x) 100% of the principal amount of the notes to be redeemed and (y) the sum of the present values of the remaining scheduled payments on such notes discounted to the date of redemption, on a semi-annual basis, at a rate equal to the sum of the applicable Treasury Rate, plus

 



 

 

 

30 basis points or (ii) on or after March 15, 2040 (six months prior to the maturity date of the notes), the redemption price for the notes will equal 100% of the principal amount of the notes.

 

 

 

Change of Control:

 

If a Change of Control Triggering Event occurs, Hospira will be required to make an offer to purchase the notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest to the date of repurchase.

 

 

 

Specified Currency:

 

U.S. Dollars (“$”)

 

 

 

Minimum Denomination:

 

$2,000 and integral multiples of $1,000 in excess thereof

 

 

 

Business Day:

 

New York

 

 

 

CUSIP:

 

441060 AL4

 

 

 

ISIN:

 

US441060AL40

 

 

 

Joint Book-Running Managers:

 

Morgan Stanley & Co. Incorporated

Citigroup Global Markets Inc.

RBS Securities Inc.

 

 

 

Co-Managers:

 

Banc of America Securities LLC

Goldman, Sachs & Co.

Mitsubishi UFJ Securities (USA), Inc.

U.S. Bancorp Investments, Inc.

Wells Fargo Securities, LLC

 

 

 

Global Settlement:

 

Through The Depository Trust Company, Euroclear or Clearstream, Luxembourg

 

The issuer has filed a registration statement (including a prospectus) with the U.S. Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offerings will arrange to send you the prospectus if you request it by calling Morgan Stanley & Co. Incorporated toll free at 1-866-718-1649, Citigroup Global Markets Inc. toll free at 1-877-858-5407, or RBS Securities Inc. toll free at 1-866-884-2071.

 

Prospectus Supplement Dated September 7, 2010

Prospectus Dated May 1, 2009

 


Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024 Click aqui para mais gráficos Hospira.
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024 Click aqui para mais gráficos Hospira.